Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsectors
Drug delivery
Gene therapy
Small molecules
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
External causes of morbidity and mortality / traumatology
Products
In development: 11
On the market: 6
Description
BridgeBio Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of genetically targeted therapies for rare genetic diseases and cancers. The company develops small molecules, gene therapies, and biologics across cardiovascular, endocrine, musculoskeletal, neurological, and genetic disorders, utilizing precision medicine and disease-pathway-based approaches. The company's key products and pipeline programs include Attruby® (acoramidis)...
